Clearside's ocular oncology partner, Aura Biosciences, is enrolling patients in its global Phase 3 CoMpass trial evaluating belzupacap sarotalocan (bel-sar) for the first-line treatment of adult ...
Afrin and Flonase are over-the-counter nasal sprays. Learn how they compare in effectiveness, side effects, and safety to ...
Suprachoroidal Delivery Develops as Promising Mainstream Procedure for Treating Multiple Macular Diseases -- SCS Microinjector® Provides ...
Harrow (HROW) announced that the Centers for Medicare & Medicaid Services CMS has approved Harrow’s transitional pass-through application ...
Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that the Centers for Medicare ...
A Review of the Research Progress and Application of Skin Care Ointments in Chronic Eczema Treatment ...
PARSIPPANY, N.J., March 14, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its ...
Detailed price information for Clearside Biomedi (CLSD-Q) from The Globe and Mail including charting and trades.
ABSTRACT: The rapid development of artificial intelligence (AI) technology is profoundly reshaping all walks of life, especially in the medical field. AI provides innovative tools for medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results